Senior insider sale
TRANSPHORM, INC. — senior position signals high conviction
$42.5K
11.60K shares
What this filing means
SMALES KELLY plans to sell 11.60K shares of TRANSPHORM, INC. valued at approximately $42.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/28/2024ACC: 0001970051-24-000014
11.60K
Shares to sell
$42.5K
Approx. market value
4K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Common Stock
COMPENSATORY PAYMENT
10/11/2023
4KTotal acquired4K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/11/2023 | Common Stock COMPENSATORY PAYMENT | 4K | — |
| Total | 4K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
766.00
Market value
$3.0K
1/2/2024
—Completed
Units to sell
2.19K
Market value
$7.9K
1/2/2024
—Completed
Units to sell
4K
Market value
$10.5K
11/22/2023
—Completed
Units to sell
656.00
Market value
$1.9K
11/20/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
4K
Market value
$19.2K
2/28/2024
Total
Units
11.60K
Value
$42.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/2/2024 | 766.00 | $3.0K | — | Completed |
1/2/2024 | 2.19K | $7.9K | — | Completed |
11/22/2023 | 4K | $10.5K | — | Completed |
11/20/2023 | 656.00 | $1.9K | — | Completed |
| Planned — Approximate Date | ||||
2/28/2024 | 4K | $19.2K | NASDAQ | Planned |
| Total | 11.60K | $42.5K | ||